Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer's disease.
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer's disease.
复制标题
DOI:
10.1186/s40478-022-01332-9
复制
发表时间:
2022-03-09
影响因子:
7.1
通讯作者:
Court FA
中科院分区:
文献类型:
--
作者:
Salvadores N;Moreno-Gonzalez I;Gamez N;Quiroz G;Vegas-Gomez L;Escandón M;Jimenez S;Vitorica J;Gutierrez A;Soto C;Court FA
Alzheimer’s disease (AD) is a major adult-onset neurodegenerative condition with no available treatment. Compelling reports point amyloid-β (Aβ) as the main etiologic agent that triggers AD. Although there is extensive evidence of detrimental crosstalk between Aβ and microglia that contributes to neuroinflammation in AD, the exact mechanism leading to neuron death remains unknown. Using postmortem human AD brain tissue, we show that Aβ pathology is associated with the necroptosis effector pMLKL. Moreover, we found that the burden of Aβ oligomers (Aβo) correlates with the expression of key markers of necroptosis activation. Additionally, inhibition of necroptosis by pharmacological or genetic means, reduce neurodegeneration and memory impairment triggered by Aβo in mice. Since microglial activation is emerging as a central driver for AD pathogenesis, we then tested the contribution of microglia to the mechanism of Aβo-mediated necroptosis activation in neurons. Using an in vitro model, we show that conditioned medium from Aβo-stimulated microglia elicited necroptosis in neurons through activation of TNF-α signaling, triggering extensive neurodegeneration. Notably, necroptosis inhibition provided significant neuronal protection. Together, these findings suggest that Aβo-mediated microglia stimulation in AD contributes to necroptosis activation in neurons and neurodegeneration. As necroptosis is a druggable degenerative mechanism, our findings might have important therapeutic implications to prevent the progression of AD. The online version contains supplementary material available at 10.1186/s40478-022-01332-9.
登录
查看更多内容
DOI:
10.1056/nejmoa1211851
发表时间:
2013-01-10
期刊:
The New England journal of medicine
影响因子:
--
作者:
Guerreiro R;Wojtas A;Bras J;Carrasquillo M;Rogaeva E;Majounie E;Cruchaga C;Sassi C;Kauwe JS;Younkin S;Hazrati L;Collinge J;Pocock J;Lashley T;Williams J;Lambert JC;Amouyel P;Goate A;Rademakers R;Morgan K;Powell J;St George-Hyslop P;Singleton A;Hardy J;Alzheimer Genetic Analysis Group
通讯作者:
Alzheimer Genetic Analysis Group
影响因子:
15.3
作者:
El Khoury, JB;Moore, KJ;Means, TK;Leung, J;Terada, K;Toft, M;Freeman, MW;Luster, AD
通讯作者:
Luster, AD
DOI:
10.3233/jad-179941
发表时间:
2018
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Cline EN;Bicca MA;Viola KL;Klein WL
通讯作者:
Klein WL
影响因子:
4.8
作者:
Kaiser, William J.;Sridharan, Haripriya;Mocarski, Edward S.
通讯作者:
Mocarski, Edward S.
影响因子:
14
作者:
通讯作者:
--